| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
184,265 | 183,383 | 196,114 | 190,448 | 196,273 |
| Cost of Revenue
|
-82,888 | -82,788 | -89,981 | -88,113 | -90,149 |
|
Gross Profit
|
101,377 | 100,595 | 106,133 | 102,335 | 106,124 |
| Selling, General and Administrative Expenses
|
-12,312 | -11,733 | -12,476 | -12,392 | -11,983 |
| Depreciation, Amortization and Depletion
|
0 | -2 | -121 | -162 | -430 |
|
Operating Income/Expenses
|
-12,312 | -11,735 | -12,597 | -12,554 | -12,413 |
|
Total Operating Profit/Loss
|
89,065 | 88,860 | 93,536 | 89,781 | 93,711 |
| Total Net Finance Income/Expense
|
-64,060 | -64,309 | -66,321 | -61,327 | -54,881 |
| Net Investment Income
|
-90,656 | -181,015 | -105,240 | -105,586 | 25,787 |
| Irregular Income/Expenses
|
37,915 | -3,169 | -29,199 | -17 | -304 |
|
Non-Operating Income/Expenses, Total
|
-116,801 | -248,493 | -200,760 | -166,930 | -29,398 |
|
Pretax Income
|
-27,736 | -159,633 | -107,224 | -77,149 | 64,313 |
|
Provision for Income Tax
|
-56 | -476 | 2,290 | -47 | -672 |
|
Net Income from Continuing Operations
|
-27,792 | -160,109 | -104,934 | -77,196 | 63,641 |
|
Discontinued Operations
|
-- | -- | -- | -- | 0 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-27,792 | -160,109 | -104,934 | -77,196 | 63,641 |
|
Net Income after Non-Controlling/Minority Interests
|
-27,792 | -160,109 | -104,934 | -77,196 | 63,641 |
|
Net Income Available to Common Stockholders
|
-27,792 | -160,109 | -104,934 | -77,196 | 63,641 |
|
Diluted Net Income Available to Common Stockholders
|
-27,792 | -160,109 | -104,934 | -77,196 | 63,641 |
|
Common Dividend per Share
|
0.25 | 0.25 | 1.08 | 2.00 | 2.00 |
| Basic EPS
|
-1.42 | -8.25 | -5.44 | -3.47 | 2.41 |
| Diluted EPS
|
-1.42 | -8.25 | -5.44 | -3.47 | 2.39 |
|
Basic Weighted Average Shares Outstanding
|
19,499.50 | 19,405 | 19,299 | 22,260 | 26,458 |
|
Diluted Weighted Average Shares Outstanding
|
19,801 | 19,666 | 19,500 | 22,410 | 26,587.50 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
34,635 | -97,013 | -42,426 | -17,314 | 117,674 |
|
EBITDA
|
46,529 | -83,833 | -29,664 | -4,880 | 118,104 |
|
Normalized EBITDA
|
24,505 | 107,698 | 114,780 | 117,650 | 60,262 |
|
Normalized Income
|
-44,094.16 | -155,530.86 | -74,462.97 | -92,418.88 | 6,403.39 |
|
Total Unusual Items
|
-22,024 | 6,185 | 31,136 | -20,630 | -57,842 |
12/31/2022 - 10/9/2003
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade